Need to include ASMD as a notified condition in the National Policy for rare diseases
ASMD is highly variable and the age of onset, specific symptoms and severity of the disorder can vary dramatically from one person to another
ASMD is highly variable and the age of onset, specific symptoms and severity of the disorder can vary dramatically from one person to another
Tele-MANAS has counseled more than 3,50,000 people till date and currently provides counseling to 2000 people through 44 Tele Manas Cells
Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide)
The cognitively operated system is a mother patent invention, first launched in India
ELREXFIO’s label contains a boxed warning for cytokine release syndrome and neurologic toxicity
Proposed acquisition represents meaningful step forward in Biogen’s strategy for sustainable growth
Deal includes DTx-1252, a potential therapy for the neuromuscular disorder Charcot-Marie-Tooth disease type 1A (CMT1A), and two additional preclinical programs for other neuroscience indications
Long COVID is a debilitating chronic condition that has affected over 100 million people globally
Pheezee is designed to assess musculoskeletal and neuromuscular health.
EIP Pharma to initiate in 2Q 2023 a Phase 2b clinical study, funded in part by a $21 million grant from the National Institute of Aging
Subscribe To Our Newsletter & Stay Updated